Demystifying diet and nutrition in MS
January 28, 2021MS Research Australia has funded 3 projects in the 2021 grant round looking at the impact of dietary factors in MS. The projects cover a wide range of possible effects…read more
News
A potential MS vaccine?
January 27, 2021A recent scientific publication has been touted as highlighting a potential vaccine for MS by some media outlets. So, what does this mean? And how does this tie in with…read more
Covid-19 at the forefront of MS research
January 27, 2021The projects cover a wide range of topics and research areas, including research into COVID-19 in people with MS in Australia.read more
Covid-19 in Ocrelizumab-treated people with Multiple Sclerosis
January 25, 2021This article, written by the Journal of Multiple Sclerosis and related disorders, (MSARD) includes data from clinical trials, post marketing safety surveillance and a US electronic medical records database, Optum.read more
Announcement: PHARMAC consultation: proposal to widen access and transition the process for funded access to multiple sclerosis treatments
November 27, 2020Pharmac have released public consultation on a proposal to widen access to funded multiple sclerosis treatments and transition access from the Multiple Sclerosis Treatment Assessment Committee (MSTAC) Panel to a…read more
2020 Webinar Series – Recordings now available
November 18, 2020These webinars cover the latest in MS research. Highlights include Dr Wallace Brownlee, who dialled in from London to update us on HSCT treatments for MS, and Justin O’Sullivan speaking…read more
New Data: Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis
November 3, 2020New data on the long term benefits of Ocrelizumab for PPMS has recently been published 29 October 2020 on the Lancet Ocrelizumab is currently funded for RRMS in New Zealand…read more
Biotin (MD1003) Fails to Prevent Disability Progression in Progressive MS Patients, Trial Shows
November 3, 2020Note: This article was originally published on www.multiplesclerosisnewstoday.com, written by Marta Figueiredo and fact checked by Patrícia Silva, PHD. MD1003, MedDay Pharmaceuticals’ high-dose biotin therapy, failed to significantly improve functional…read more
Accessibility Research Participants Wanted
July 14, 2020Access Advisors provides digital accessibility consultance services around the country. They also regularly recruit people with access needs who are interested in doing research for some of the more enlightened…read more
Survey on Psychological Support in Multiple Sclerosis
July 14, 2020A survey exploring participants’ perspectives of people living with Multiple Sclerosis to better understand adjustment to diagnosis and the role of psychological support in the patient journey.read more
Keep up to date on the latest MS and COVID-19 data
July 14, 2020Keep up with the latest researching on COVID-19 as it relates to Multiple Sclerosisread more
Exploring medicinal use of cannabis in a time of policy change in New Zealand
July 13, 2020Exploring patterns of medicinal cannabis use prior to implementation of the new Medicinal Cannabis Scheme (MCS) in New Zealand.read more
Survey on the use of Cannabis as Medicine
July 9, 2020Karen Oldfield is a Doctoral student in Clinical Research at Victoria University of Wellington and Medical Research Fellow at the Medical Research Institute of New Zealand. Her PhD is exploring…read more